Activation of phosphatidylinositol 3-kinase is required for tumor necrosis factor-α-induced upregulation of matrix metalloproteinase-9: Its direct inhibition by quercetin

International Journal of Biochemistry and Cell Biology

Volumn 41, Issue 7, 2009, Pages 1592-1600

  Hwang, Mun Kyung ^a,b   Song, Nu Ry ^a   Kang, Nam Joo ^a,b   Lee, Ki Won ^b   Lee, Hyong Joo ^a  

^a Seoul National University   (South Korea)

^b Konkuk University   (South Korea)

Author keywords

Matrix metalloproteinaes 9; Phosphatidylinositol 3 kinase; Quercetin; Tumor necrosis factor

Indexed keywords

FLAVONOID; GELATINASE B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LUCIFERASE; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; POLYPHENOL DERIVATIVE; PROTEIN KINASE B; QUERCETIN; RESVERATROL; TRANSCRIPTION FACTOR AP 1; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL MIGRATION; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; ENZYME REGULATION; EPIDERMIS CELL; PHENOTYPE; RED WINE; WESTERN BLOTTING;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; CELL LINE; CELL MOVEMENT; COMPLEX MIXTURES; ENZYME ACTIVATION; MATRIX METALLOPROTEINASE 9; MICE; NF-KAPPA B; PHOSPHORYLATION; PROTEIN BINDING; PROTO-ONCOGENE PROTEINS C-AKT; QUERCETIN; STILBENES; TRANSCRIPTION FACTOR AP-1; TRANSCRIPTIONAL ACTIVATION; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION; WINE;

EID: 63049132131     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biocel.2009.01.014     Document Type: Article

References (50)

1. Aggarwal B.B. Signalling pathways of the TNF superfamily: a double-edged sword. Nat Rev Immunol 3 (2003) 745-756
2. Agullo G., Gamet-Payrastre L., Manenti S., Viala C., Remesy C., Chap H., et al. Relationship between flavonoid structure and inhibition of phosphatidylinositol 3-kinase: a comparison with tyrosine kinase and protein kinase C inhibition. Biochem Pharmacol 53 (1997) 1649-1657
3. Baxter N.J., Lilley T.H., Haslam E., and Williamson M.P. Multiple interactions between polyphenols and a salivary proline-rich protein repeat result in complexation and precipitation. Biochemistry 36 (1997) 5566-5577
4. Briviba K., Pan L., and Rechkemmer G. Red wine polyphenols inhibit the growth of colon carcinoma cells and modulate the activation pattern of mitogen-activated protein kinases. J Nutr 132 (2002) 2814-2818
5. Chakraborti S., Malay M., Das S., Mandal A., and Chakraborti T. Regulation of matrix metalloproteinases: an overview. Mol Cell Biochem 253 (2003) 269-285
6. Chung J.Y., Park J.O., Phyu H., Dong Z., and Yang C.S. Mechanisms of inhibition of the Ras-MAP kinase signaling pathway in 30.7b Ras 12 cells by tea polyphenols (-)-epigallocatechin-3-gallate and theaflavin-3,3′-digallate. FASEB J 15 (2001) 2022-2024
7. Cully M., You H., Levine A.J., and Mak T.W. Beyond PTEN mutations: the PI3K pathway as an integrator of multiple inputs during tumorigenesis. Nat Rev Cancer 6 (2006) 184-192
8. Damianaki A., Bakogeorgou E., Kampa A., Notas G., Hatzoglou A., Panagiotou S., et al. Potent inhibitory action of red wine polyphenols on human breast cancer cells. J Cell Biochem 78 (2000) 429-441
9. De Azevedo Jr. W.F., Mueller-Dieckmann H.J., Schulze-Gahmen U., Worland P.J., Sausville E., and Kim S.H. Structural basis for specificity and potency of a flavonoid inhibitor of human CDK2, a cell cycle kinase. Proc Natl Acad Sci USA 93 (1996) 2735-2740
10. Dong Z., Birrer M.J., Watts R.G., Matrisian L.M., and Colburn N.H. Blocking of tumor promoter-induced AP-1 activity inhibits induced transformation in JB6 mouse epidermal cells. Proc Natl Acad Sci USA 91 (1994) 609-613
11. German J.B., and Walzem R.L. The health benefits of wine. Annu Rev Nutr 20 (2000) 561-593
12. Gosslau A., Chen M., Ho C.T., and Chen K.Y. A methoxy derivative of resveratrol analogue selectively induced activation of the mitochondrial apoptotic pathway in transformed fibroblasts. Br J Cancer 92 (2005) 513-521
13. Gum R., Lengyel E., Juarez J., Chen J.H., Sato H., Seiki M., et al. Stimulation of 92-kDa gelatinase B promoter activity by ras is mitogen-activated protein kinase kinase 1-independent and requires multiple transcription factor binding sites including closely spaced PEA3/ets and AP-1 sequences. J Biol Chem 271 (1996) 10672-10680
14. Huang C., Ma W.Y., Young M.R., Colburn N., and Dong Z. Shortage of mitogen-activated protein kinase is responsible for resistance to AP-1 transactivation and transformation in mouse JB6 cells. Proc Natl Acad Sci USA 95 (1998) 156-161
15. Huang Q., Shen H.M., and Ong C.N. Inhibitory effect of emodin on tumor invasion through suppression of activator protein-1 and nuclear factor-κB. Biochem Pharmacol 68 (2004) 361-371
16. Ichimatsu D., Nomura M., Nakamura S., Moritani S., Yokogawa K., Kobayashi S., et al. Structure-activity relationship of flavonoids for inhibition of epidermal growth factor-induced transformation of JB6 Cl 41 cells. Mol Carcinogen 46 (2007) 436-445
17. Inomata S., Matsunaga Y., Amano S., Takada K., Kobayashi K., Tsunenaga M., et al. Possible involvement of gelatinases in basement membrane damage and wrinkle formation in chronically ultraviolet B-exposed hairless mouse. J Invest Dermatol 120 (2003) 128-134
18. Jang M., Cai L., Udeani G.O., Slowing K.V., Thomas C.F., Beecher C.W., et al. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 275 (1997) 218-220
19. Kim D., Kim S., Koh H., Yoon S.O., Chung A.S., Cho K.S., et al. Akt/PKB promotes cancer cell invasion via increased motility and metalloproteinase production. FASEB J 15 (2001) 1953-1962
20. Lee C.W., Lin C.C., Lin W.N., Liang K.C., Luo S.F., Wu C.B., et al. TNF-alpha induces MMP-9 expression via activation of Src/EGFR PDGFR/PI3K/Akt cascade and promotion of NF-kappaB/p300 binding in human tracheal smooth muscle cells. Am J Physiol Lung Cell Mol Physiol 292 (2007) L799-812
21. Lee K.W., Kang N.J., Heo Y.S., Rogozin E.A., Pugliese A., Hwang M.K., et al. Raf and MEK protein kinases are direct molecular targets for the chemopreventive effect of quercetin, a major flavonol in red wine. Cancer Res 68 (2008) 946-955
22. Lee K.W., and Lee H.J. The roles of polyphenols in cancer chemoprevention. BioFactors 26 (2006) 105-121
23. Lim E.J., Lee S.H., Lee J.G., Chin B.R., Bae Y.S., Kim J.R., et al. Activation of toll-like receptor-9 induces matrix metalloproteinase-9 expression through Akt and tumor necrosis factor-alpha signaling. FEBS Lett 580 (2006) 4533-4538
24. Lu F.J., Tseng T.H., Lee W.J., Yen C.C., Yin Y.F., Liao C.W., et al. Promoting neoplastic transformation of humic acid in mouse epidermal JB6 Cl41 cells. Chem Biol Interact 162 (2006) 249-258
25. 1 cell cycle arrest and inhibits MMP-9 expression via the regulation of NF-κB and AP-1 in vascular smooth muscle cells. Arch Biochem Biophys 421 (2004) 267-276
26. Moore R.J., Owens D.M., Stamp G., Arnott C., Burke F., East N., et al. Mice deficient in tumor necrosis factor-alpha are resistant to skin carcinogenesis. Nat Med 5 (1999) 828-831
27. Nabeshima K., Inoue T., Shimao Y., and Sameshima T. Matrix metalloproteinases in tumor invasion: role for cell migration. Pathol Int 52 (2002) 255-264
28. Oak M.H., Chataigneau M., Keravis T., Chataigneau T., Beretz A., Andriantsitohaina R., et al. Red wine polyphenolic compounds inhibit vascular endothelial growth factor expression in vascular smooth muscle cells by preventing the activation of the p38 mitogen-activated protein kinase pathway. Arterioscler Thromb Vasc Biol 23 (2003) 1001-1007
29. Oak M.H., El Bedoui J., Anglard P., and Schini-Kerth V.B. Red wine polyphenolic compounds strongly inhibit pro-matrix metalloproteinase-2 expression and its activation in response to thrombin via direct inhibition of membrane type 1-matrix metalloproteinase in vascular smooth muscle cells. Circulation 110 (2004) 1861-1867
30. Overall C.M., and Lopez-Otin C. Strategies for MMP inhibition in cancer: innovations for the post-trial era. Nat Rev Cancer 2 (2002) 657-672
31. Pincheira R., Castro A.F., Ozes O.N., Idumalla P.S., and Donner D.B. Type 1 TNF receptor forms a complex with and uses Jak2 and c-Src to selectively engage signaling pathways that regulate transcription factor activity. J Immunol 181 (2008) 1288-1298
32. Ribeiro M.T., Waffo-Teguo P., Teissedre P.L., Pujolas A., Vercauteren J., Cabanis J.C., et al. Determination of stilbenes (trans-astringin, cis- and trans-piceid, and cis- and trans-resveratrol) in Portuguese wines. J Agric Food Chem 47 (1999) 2666-2670
33. Rijken F., Kiekens R.C., van den Worm E., Lee P.L., van Weelden H., and Bruijnzeel P.L. Pathophysiology of photoaging of human skin: focus on neutrophils. Photochem Photobiol Sci 5 (2006) 184-189
34. Ruth M.C., Xu Y., Maxwell I.H., Ahn N.G., Norris D.A., and Shellman Y.G. RhoC promotes human melanoma invasion in a PI3K/Akt-dependent pathway. J Invest Dermatol 126 (2006) 862-868
35. Samuel S., and Bernstein L.R. Adhesion, migration, transcriptional, interferon-inducible, and other signaling molecules newly implicated in cancer susceptibility and resistance of JB6 cells by cDNA microarray analyses. Mol Carcinogen 39 (2004) 34-60
36. Sarkar F.H., and Li Y. Cell signaling pathways altered by natural chemopreventive agents. Mutat Res 555 (2004) 53-64
37. She Q.B., Bode A.M., Ma W.Y., Chen N.Y., and Dong Z. Resveratrol-induced activation of p53 and apoptosis is mediated by extracellular-signal-regulated protein kinases and p38 kinase. Cancer Res 61 (2001) 1604-1610
38. She Q.B., Huang C., Zhang Y., and Dong Z. Involvement of c-jun NH(2)-terminal kinases in resveratrol-induced activation of p53 and apoptosis. Mol Carcinogen 33 (2002) 244-250
39. Suganuma M., Okabe S., Marino M.W., Sakai A., Sueoka E., and Fujiki H. Essential role of tumor necrosis factor alpha (TNF-alpha) in tumor promotion as revealed by TNF-alpha-deficient mice. Cancer Res 59 (1999) 4516-4518
40. Suzukawa K., Weber T.J., and Colburn N.H. AP-1, NF-kappa-B, and ERK activation thresholds for promotion of neoplastic transformation in the mouse epidermal JB6 model. Environ Health Perspect 110 (2002) 865-870
41. Szlosarek P., Charles K.A., and Balkwill F.R. Tumour necrosis factor-[alpha] as a tumour promoter. Eur J Cancer 42 (2006) 745-750
42. Vivanco I., and Sawyers C.L. The phosphatidylinositol 3-kinase AKT pathway in human cancer. Nat Rev Cancer 2 (2002) 489-501
43. Warner R.L., Bhagavathula N., Nerusu K.C., Lateef H., Younkin E., Johnson K.J., et al. Matrix metalloproteinases in acute inflammation: induction of MMP-3 and MMP-9 in fibroblasts and epithelial cells following exposure to pro-inflammatory mediators in vitro. Exp Mol Pathol 76 (2004) 189-195
44. Waterhouse A.L. Wine phenolics. Ann N Y Acad Sci 957 (2002) 21-36
45. Westermarck J., and Kahari V.M. Regulation of matrix metalloproteinase expression in tumor invasion. FASEB J 13 (1999) 781-792
46. Wymann M.P., Zvelebil M., and Laffargue M. Phosphoinositide 3-kinase signalling-which way to target?. Trends Pharmacol Sci 24 (2003) 366-376
47. Yan C., and Boyd D.D. Regulation of matrix metalloproteinase gene expression. J Cell Physiol 211 (2007) 19-26
48. Yoeli-Lerner M., and Toker A. Akt/PKB signaling in cancer: a function in cell motility and invasion. Cell Cycle 5 (2006) 603-605
49. Yoon S.O., Shin S., Lee H.J., Chun H.K., and Chung A.S. Isoginkgetin inhibits tumor cell invasion by regulating phosphatidylinositol 3-kinase/Akt-dependent matrix metalloproteinase-9 expression. Mol Cancer Ther 5 (2006) 2666-2675
50. Young M.R., Li J.J., Rincón M., Flavell R.A., Sathyanarayana B.K., Hunziker R., et al. Transgenic mice demonstrate AP-1 (activator protein-1) transactivation is required for tumor promotion. Proc Natl Acad Sci USA 96 (1999) 9827-9832